Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cytovia

M&A STATUS
Corporate LATEST DEAL TYPE (Cancelled)
3 FINANCING ROUNDS
Description

Developer of bio-medicines and drugs. The company's bio-medicines and drugs include a patented drug screening technology and discovers and develops small-molecule inhibitors and activators of capsules, enabling the patients to get cured from cancer.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Primary Office
  • 6650 Nancy Ridge Drive
  • San Diego, CA 92121
  • United States

+1 (858) 000-0000

Cytovia Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cytovia‘s full profile, request access.

Request full access to PitchBook

Cytovia Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Cytovia‘s full profile, request access.

Request full access to PitchBook

Cytovia Executive Team (4)

Name Title Board
Seat
Contact
Info
Daniel Teper Chief Executive Officer

3 Former Executives

You’re viewing 1 of 4 executives. Get the full list »